UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carbazole scaffolds in cancer therapy: a review from 2012 to 2018

Journal of enzyme inhibition and medicinal chemistry, 2019-01, Vol.34 (1), p.1321-1346

2019

Volltextzugriff (PDF)

Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators

Journal of medicinal chemistry, 2012-05, Vol.55 (9), p.4027-4061

2012

Volltextzugriff (PDF)

Structural basis of ligand recognition at the human MT1 melatonin receptor

Nature (London), 2019-05, Vol.569 (7755), p.284-288

2019

Volltextzugriff (PDF)

XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity

Nature (London), 2019-04, Vol.569 (7755), p.289-292

2019

Volltextzugriff (PDF)

Melatonin facts: Lack of evidence that melatonin is a radical scavenger in living systems

Journal of pineal research, 2024-01, Vol.76 (1), p.e12926-n/a

2024

Volltextzugriff (PDF)

Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists

Molecules (Basel, Switzerland), 2024-08, Vol.29 (16), p.3847

2024

Volltextzugriff (PDF)

Design of experiments for enantiomeric separation in supercritical fluid chromatography

Journal of pharmaceutical and biomedical analysis, 2016-02, Vol.120, p.297-305

2016

Volltextzugriff (PDF)

High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists

European journal of medicinal chemistry, 2022-11, Vol.241 (5), p.114620-114620, Article 114620

2022

Volltextzugriff (PDF)

Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine

European journal of medicinal chemistry, 2020-03, Vol.189, p.112078-112078, Article 112078

2020

Volltextzugriff (PDF)

A Putative New Melatonin Binding Site in Sheep Brain, MTx : Preliminary Observations and Characteristics

The Journal of pharmacology and experimental therapeutics, 2022-01, Vol.380 (1), p.76-89

2022

Volltextzugriff (PDF)

(Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators

Journal of enzyme inhibition and medicinal chemistry, 2019-01, Vol.34 (1), p.224-229

2019

Volltextzugriff (PDF)

Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors

ACS chemical neuroscience, 2022-05, Vol.13 (9), p.1382-1394

2022

Volltextzugriff (PDF)

Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver

Arteriosclerosis, thrombosis, and vascular biology, 2009-10, Vol.29 (10), p.1488-1495

2009

Volltextzugriff (PDF)

Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT1/MT2) and serotoninergic (5-HT2C) dual ligands

European journal of medicinal chemistry, 2017-12, Vol.141, p.552-566

2017

Volltextzugriff (PDF)

Enhanced detection for determination of enantiomeric purity of novel agomelatine analogs by EKC using single and dual cyclodextrin systems

Electrophoresis, 2014-10, Vol.35 (19), p.2785-2792

2014

Volltextzugriff (PDF)

Synthesis and SAR Studies of Isoquinoline and Tetrahydroisoquinoline Derivatives as Melatonin Receptor Ligands

ChemMedChem, 2022-02, Vol.17 (3), p.e202100658-n/a

2022

Volltextzugriff (PDF)

New phenylaniline derivatives as modulators of amyloid protein precursor metabolism

Bioorganic & medicinal chemistry, 2018-05, Vol.26 (8), p.2151-2164

2018

Volltextzugriff (PDF)

The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia

Arteriosclerosis, thrombosis, and vascular biology, 2006-12, Vol.26 (12), p.2731-2737

2006

Volltextzugriff (PDF)

Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structure

Bioorganic & medicinal chemistry, 2018-07, Vol.26 (12), p.3296-3307

2018

Volltextzugriff (PDF)

Enantioseparation and thermodynamic study of naphthalene derivatives, new melatoninergic agonists, on coated amylose [tris(S)-1-phenylethylcarbamate] stationary phase. Transposition to preparative scale

Biomedical chromatography, 2015-05, Vol.29 (5), p.689-697

2015

Volltextzugriff (PDF)

New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation

European journal of medicinal chemistry, 2017-02, Vol.127, p.621-631

2017

Volltextzugriff (PDF)

Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I)

European journal of medicinal chemistry, 2012-03, Vol.49, p.310-323

2012

Volltextzugriff (PDF)

New melatonin (MT1/MT2) ligands: Design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives

Bioorganic & medicinal chemistry, 2014-02, Vol.22 (3), p.986-996

2014

Volltextzugriff (PDF)

New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors

International journal of molecular sciences, 2013-04, Vol.14 (5), p.8948-8962

2013

Volltextzugriff (PDF)

Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives

European journal of medicinal chemistry, 2016-02, Vol.109, p.360-370

2016

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Englisch
(161)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Carbazole scaffolds in cancer therapy: a review from 2012 to 2018

Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators

Structural basis of ligand recognition at the human MT1 melatonin receptor

XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity

Melatonin facts: Lack of evidence that melatonin is a radical scavenger in living systems

Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists

Design of experiments for enantiomeric separation in supercritical fluid chromatography

High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists

Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine

A Putative New Melatonin Binding Site in Sheep Brain, MTx : Preliminary Observations and Characteristics

(Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators

Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors

Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver

Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT1/MT2) and serotoninergic (5-HT2C) dual ligands

Enhanced detection for determination of enantiomeric purity of novel agomelatine analogs by EKC using single and dual cyclodextrin systems

Synthesis and SAR Studies of Isoquinoline and Tetrahydroisoquinoline Derivatives as Melatonin Receptor Ligands

New phenylaniline derivatives as modulators of amyloid protein precursor metabolism

The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia

Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structure

Enantioseparation and thermodynamic study of naphthalene derivatives, new melatoninergic agonists, on coated amylose [tris(S)-1-phenylethylcarbamate] stationary phase. Transposition to preparative scale

New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation

Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I)

New melatonin (MT1/MT2) ligands: Design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives

New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors

Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives

Suchergebnisse filtern